SARS-CoV-2 (COVID-19) South African variant (B.1.351) S RBD (K417N, E484K, N501Y) Recombinant Protein | 20-184

SARS-CoV-2 (COVID-19) South African variant (B.1.351) S RBD (K417N, E484K, N501Y) Recombinant Protein | 20-184 | Gentaur UK, US & Europe Distribution

Tested Application: E, WB

Application: SDS-PAGE

Tpredicted Molecular Weight: N/A

Physical State: Lyophilized

Buffer: 20mM PB (pH 7.4). 5 % trehalose is added as a protectant before lyophilization.

Storage Condition: Store in working aliquots at -20˚C. Avoid freeze/thaw cycles.

Alternate Name: S protein RBD, Spike glycoprotein Receptor-binding domain, S glycoprotein RBD, Spike protein RBD

Background: N/A

Shipping: N/A

Disclaimer: Products are intended for laboratory research purposes only and should be used by qualified personnel only. They are not intended for use in humans. ProSci is not liable for damages or injuries resulting from receipt and/or use of ProSci materials. Please refer to the Material Safety Data Sheet (MSDS) for safe storage, handling, and use procedures.

Source: HEK293 cells

Species: SARS Spike Protein

By Source: Human Cells

By Species: Other

Fusion Tag: His

Sequence: Arg319-Phe541 (N501Y, K417N, E484K)

Bological Activity: N/A

Purity: > 95% as determined by Bis-Tris PAGE; > 95% as determined by HPLC

Endotoxin level is less than 1EU per ug by the LAL method.